原发于鼻咽非霍奇金淋巴瘤90例临床分析  

Clinical Analysis of 90 Patients with Primary Non-Hodgkin's Lymphoma of the Nasopharynx Stage Ⅰ or Ⅱ

作　　者：范长根[1] 韩亚骞[1] 陈艳平[1] 胡炳强[1] 

机构地区：[1]湖南省肿瘤医院,湖南长沙410013

出　　处：《四川肿瘤防治》2006年第4期239-241,共3页Sichuan Journal of Cancer Control

摘　　要：目的：探讨Ⅰ、Ⅱ期鼻咽非霍奇金淋巴瘤（NHL）的治疗方法。方法：1995年1月-2001年1月我院收治Ⅰ、Ⅱ期鼻咽非霍奇金淋巴瘤90例，采用单纯放射治疗及放射治疗加化疗。结果：Ⅰ期患者单纯放疗组3、5年生存率分别为94．4％、88．9％，放疗加化疗组3、5年生存率分别为92．3％、84．6％。Ⅱ期中度恶性的患者单纯放疗组3、5年生存率分别为62．5％、50％，放疗加化疗组3、5年生存率分别为92．9％、85．7％。结论：Ⅰ期鼻咽非霍奇淋巴瘤可采用单纯放射治疗。Ⅱ期中度恶性鼻咽非霍奇淋巴瘤采用综合治疗。Objective： To evaluate the treatment policy for stage Ⅰ and Ⅱ non-Hodgkin＇ s lymphoma（NHL） of the nasopharynx. Methods： Ninety Patients with stage Ⅰ or Ⅱ NHL of the nasopharynx were treated from January 1995 to January 2001, the methods of treatment included radiotherapy alone and radiotherapy combined with chemotherapy. Results： For patients with stage Ⅰ , the 3 and 5 year survival rates in radiotherapy alone group and in radiotherapy combined with chemotherapy group were 94. 4%, 88.9% and 92. 3%, 84.6% respectivly. For patients with stage Ⅱ , the 3 and 5 year survival rates were 62. 5%, 50% in radiotherapy alone group and 92. 9%, 85.7% in radiotherapy combined with the chemotherapy group respectively. Conclusion： For patients with stage Ⅰ NHL of nasopharynx, radiotherapy alone can be used, and the comprehensive therapy may be optimal for the stage Ⅱ NHL.

关 键 词：鼻咽肿瘤 非霍奇金淋巴瘤 放射治疗 综合治疗 

分 类 号：R739.63[医药卫生—肿瘤]